Fig. 5From: Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitorsIncreased sensitivity of HR deficient cells to IGF-1Rki. Clonogenic survival assay was performed in the presence of increasing doses of IGF-1Rki in ovarian (a) and breast (b) cancer cells. Results represent the average of four independent experimentsBack to article page